miércoles, 16 de noviembre de 2011

Otsuka & Lundbeck unidos por...5.


"I think this is a major response to what is widely seen as a problem," Iwamoto told Reuters in an interview.
Lundbeck will acquire rights to two compounds which the Danish group said could realise total accumulated revenue of more than 50 billion Danish crowns ($9.1 billion) if fully developed and marketed.
"This is the biggest partnership agreement in Lundbeck's history," said Chief Executive Ulf Wiinberg in the statement.
"We will have a very complete psychiatry portfolio with the agreement," he said by telephone.

SEEKING LONG TERM GROWTH

The agreement combines Otsuka's expertise in anti-psychotic drugs and relatively strong presence in the United States and Asia with Lundbeck's expertise in anxiety and depression treatments and presence in Europe.
Más

No hay comentarios: